Skip to main content
. Author manuscript; available in PMC: 2010 Jul 1.
Published in final edited form as: Cancer Res. 2009 Jun 23;69(13):5450–5457. doi: 10.1158/0008-5472.CAN-08-4031

Table 2.

Table 2A. Oxidant response (EC50 measurements) in WEHI7.2 cells treated with MnTE-2-PyP5+
Treatment H2O2
(µM)		 Paraquat
(µM)
Control 104.9 ± 5.4 44.6 ± 1.3
0.75 µM MnTE-2-PyP5+ 102.8 ± 6.7 59.8 ± 1.6*
1.5 µM MnTE-2-PyP5+ 61.7 ± 1.7* 63.7 ± 6.0*
Table 2B. Chemotherapeutic drug response (EC50 measurements) of WEHI7.2 cells pre-treated with MnTE-2-PyP5+
Treatment Cyclophosphamide
(mM)		 Doxorubicin
(nM)		 Vincristine
(nM)
Control 2.25 ± 0.10 10.3 ± 0.9 2.1 ± 0.1
0.75 µM MnTE-2-PyP5+ 1.07 ± 0.08* 9.6 ± 0.3 2.3 ± 0.2
1.5 µM MnTE-2-PyP5+ 0.73 ± 0.04* 10.3 ± 0.2 1.9 ± 0.2
*

denotes significantly different from untreated WEHI7.2 (control) cells (p ≤ 0.05). Values represent the mean ± S.E.M.; n = 3.

*

denotes significantly different from untreated WEHI7.2 (control) values (p ≤ 0.05). Values represent the mean ± S.E.M. (n=3 or 4).